Masimo says study backs its pulse oximetry for different skin colors
Masimo announced today that a study of its Masimo SET pulse oximetry demonstrated no difference in accuracy for different skin colors.
Related Articles
Value creation through business model innovation in US healthcare
Value creation in US healthcare has grown through innovative business models but much opportunity remains, even among the fastest-growing organizations.
Included Health launches virtual specialty care clinic with initial focus on cancer, weight loss and menopause
Virtual care and health navigation company Included Health plans to launch a virtual-first specialty care clinic to give its members easier access to more than…
Neurology-focused NeuroX will participate in CMS’ GUIDE Program
The virtual brain health company and its physician network, ATP Partners, will offer online services to help patients with dementia remain in their homes.
Lilly obesity drug shows benefit in sleep disorder study, pointing to new use
Positive data for Lilly’s medicine tirzepatide in sleep apnea are the latest signal the benefits of GLP-1 agonists could extend beyond diabetes and weight loss.
Reproductive health company Stork Club announces expanded offerings
Employers with the reproductive and family-building service’s global coverage will now have access to more than 8,000 providers globally.
RSNA and GE HealthCare Bring Advanced Mammography Technology to Tanzania to Improve Access and Help Address Breast Cancer Mortality Rate
• Radiologists at Muhimbili National Hospital, part of the Muhimbili University of Health and Sciences and the largest public hospital in
Emergency healthcare startup Medulance raises $3 million
New Delhi-based startup Medulance has raised funds after running as a profitable bootstrapped company for six years. This round also saw participation from investors such…
Kidney care startup VitusCare raises $2.7 million from Tomorrow Capital, others
In the health-tech startup space, emergency healthcare services provider Medulance has also raised $3 million in a Series A round of funding today.
How Eko Health’s AI-powered stethoscope detects early signs of heart failure
Eko Health taps tech old and new for its cardiac algorithms — and has sights set on the lungs next, co-founder and CEO Connor Landgraf says.
Labcorp launches blood test for neurodegenerative diseases detection
Global life sciences company Labcorp has announced the first commercially available GFAP blood biomarker test in the US.